PubMed Health⌕ Search

PubMed · 10132931

FDA's mammography facility quality assurance program.

Abstract

To summarize, the key features of the MQSA program are: To operate lawfully after October 1, 1994, a mammography facility must be certified by FDA as providing quality mammography services. For a facility to be certified, it must be accredited by a federally-approved private nonprofit or state accreditation body. To be accredited, the facility must undergo periodic review of its clinical images and meet federally-developed quality standards for personnel qualifications, quality assurance programs, and recordkeeping and reporting. To maintain its certification, the facility must pass an annual inspection conducted by federal or state personnel. If congress grants FDA authority, the agency will establish interim standards initially but will eventually replace them with more comprehensive final standards. After October 1, 1994, mammography facilities unable to comply with the quality standards in effect at a given time will not be permitted to continue in operation. FDA believes that once the comprehensive standards and inspection program are in place, the goal of assuring all women access to quality mammography will soon be reached.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Kivel. 1994. FDA's mammography facility quality assurance program.. https://pubmed.ncbi.nlm.nih.gov/10132931/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Strategies to reduce HIV risk behavior in HIV primary care clinics: brief provider messages and specialist intervention.

Reducing HIV transmission is a critical goal worldwide, prompting new strategies to slow the spread of the virus. This paper describes the theoretical underpinnings of the Comprehensive Harm Reduction Protocol (CHRP) and the process of its implementation in one large urban HIV clinic and two smaller rural primary care clinics. Patients enrolled in CHRP complete the Risk Diagnostic Questionnaire (RDQ), self-reporting HIV transmission risk behavior at most clinic visits. Clinicians review RDQs to trigger dialogue using motivational interviewing and the stages of health behavior change to reduce high-risk behaviors (drug use, alcohol use, or high-risk sexual behavior). In the ongoing evaluation study, CHRP patients receive two provider-only visits before being randomized to continue with provider brief prevention messages only or to receive additional intensive counseling with a risk-reduction specialist following the provider visit. If outcome data support one or both interventions, CHRP could be a useful model for widespread adoption. Observations from the implementation of this protocol are presented in order to facilitate the adoption of this protocol in interested clinics. Later, results of the evaluation of the implementation of the protocol may have value in developing prevention policy in HIV treatment clinics.

Ambulatory Care Facilities↗